PINNACLE ASSOCIATES LTD - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$176,000
-61.0%
10,775
-59.8%
0.00%
-62.5%
Q2 2021$451,000
-54.5%
26,825
-50.6%
0.01%
-57.9%
Q1 2021$991,000
+8.3%
54,275
+7.9%
0.02%0.0%
Q4 2020$915,000
+29.6%
50,300
+27.2%
0.02%
+11.8%
Q3 2020$706,000
-60.9%
39,550
-60.7%
0.02%
-61.4%
Q2 2020$1,804,000
-24.1%
100,615
-35.7%
0.04%
-38.9%
Q1 2020$2,376,000
-25.3%
156,515
-2.9%
0.07%
+2.9%
Q4 2019$3,179,000
+16.7%
161,140
+1.7%
0.07%
+9.4%
Q3 2019$2,725,000
+4.0%
158,440
+7.0%
0.06%
+4.9%
Q2 2019$2,621,000
+0.4%
148,057
+15.5%
0.06%
+3.4%
Q1 2019$2,610,000128,1490.06%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders